Institute for Bioprocessing and Analytical Measurement Techniques e.V.

What Institute for Bioprocessing and Analytical Measurement Techniques e.V. does

The Institute for Bioprocessing and Analytical Measurement Techniques e.V. (iba) is a non-profit research institute (eingetragener Verein) headquartered in Heilbad Heiligenstadt, Thuringia, Germany, founded in 1991. It operates three research departments — Analysenmesstechnik (analytical measurement), Bioprozesstechnik (bioprocess technology), and Biowerkstoffe (biomaterials) — plus junior research groups, and employs approximately 33 staff.

Its technology portfolio centers on microfluidics (including a proprietary droplet-based 3DµHTS screening platform integrating imaging, Raman, and Gigahertz spectroscopy with AI-supported multi-parameter analysis), broadband bioimpedance spectroscopy spanning mHz to 100 GHz, two-photon polymerization for sub-micron 3D scaffold fabrication, hiPSC-based 3D tissue and organ-on-chip models, and surface functionalization using tetraether lipid (TEL) and polyelectrolyte multilayer (PEM) coatings. Application areas include drug discovery, tumor modeling, thrombosis diagnostics, biofilm research, environmental water monitoring, and medical implant coatings.

The institute does not sell commercial products. Revenue is generated entirely through publicly funded research grants from German federal agencies (BMBF, BMWi, DFG), the Thuringian state government, and EU programs (EFRE, ESF+), supplemented by contract research and collaborations with academic and industrial partners including Universitätsklinikum Jena and Microfluidic ChipShop GmbH. Customers and beneficiaries are academic and clinical research institutions, medical technology and biotechnology companies, and environmental technology users, accessed through collaborative projects and direct engagement rather than commercial sales channels.

Name

Institute for Bioprocessing and Analytical Measurement Techniques e.V.

Legal name

Institut für Bioprozess- und Analysenmesstechnik e.V.

Website

https://iba-heiligenstadt.de

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

The Institute for Bioprocessing and Analytical Measurement Techniques e.V. (iba) is a German non-profit research institute developing microfluidic, bioimpedance, and 3D cell culture platforms — including the AI-supported 3DµHTS screening system — for academic, clinical, and industrial partners in medicine, biotechnology, and the environment, funded by public research grants.

Ownership category

akta.pro rank

Product category

Biotechnology Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Analytical Laboratory Instrument Manufacturing (334516)

SIC

Services-Commercial Physical & Biological Research (8731), Laboratory Analytical Instruments (3826), Services-Testing Laboratories (8734)

akta.pro primary industry

Automation, Controls & Manufacturing Execution for Bioprocessing (SCADA/DCS/PLC/MES) (HLAAAJAE)

akta.pro secondary industries

Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE), Biosensors & Lab-on-Chip (BioMEMS) (HDAHALAK)

Keywords

• Bioprocess engineering research
• Analytical measurement techniques
• Microfluidic platform development
• 3D cell culture models
• Bioimpedance spectroscopy

Headquarters

HQ city

Heilbad Heiligenstadt

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Distribution channels1 record

Marketing channels4 records

Core offering

The institute is a non-university research institution that conducts application-oriented research in bioprocess engineering, analytical measurement techniques, biomaterials, and microfluidics. It offers research services, contract research, and access to specialized technology platforms — including a droplet-based microfluidic high-throughput screening platform, bioimpedance spectroscopy systems, two-photon polymerization fabrication, organ-on-a-chip platforms, biosensor development, and biomaterial surface functionalization — to academic and industrial partners.

Product overview

The Institute for Bioprocess and Analytical Measurement Techniques (IBA) operates as a non-university research institution offering specialized research services and technology platforms rather than commercial products. The core offerings include the 3DµHTS microfluidic screening platform for automated 3D cell cultivation and drug testing, modular microfluidic systems (pipe-based bioreactors, perfusion systems), bioimpedance spectroscopy systems for biological material characterization, and two-photon polymerization services for 3D scaffold fabrication. Additional services encompass organ-on-a-chip platform development, custom biosensor development, and biomaterial surface functionalization using advanced coating technologies. These integrated offerings enable applications in personalized medicine, tumor research, drug discovery, and medical device development.

Differentiator

Problem solved

Functional benefit

Products and services

• 3DµHTS Platform (3D-Mikro-Hochdurchsatz-Screening) A droplet-based microfluidic platform for automated 3D cell cultivation and high-throughput drug screening, combining spheroid development, imaging, Raman spectroscopy, and Gigahertz analysis with AI-supported multiparameter evaluation. Targeted at pharmaceutical and academic researchers conducting drug discovery and disease modeling.
• Modular Microfluidic Systems Pipe-based bioreactors and perfusion systems on polymer chip basis for parallelized cell cultivation, drug screening, and virus infection analysis with integrated sensor technology. Targeted at academic and industrial research users.
• Bioimpedance Spectroscopy Systems Broadband electrical impedance spectroscopy (EIS) systems from millihertz to 100 GHz for rapid characterization of biological materials, biofilm detection, and process monitoring in bio-, medical, food, and environmental technology applications. Targeted at research institutions and industrial laboratories.
• Two-Photon Polymerization (2PP) Fabrication Services 3D printing services using two-photon polymerization for fabrication of cell scaffolds, bone-cartilage implants, and microstructured components with sub-micron resolution for tissue engineering applications. Targeted at tissue engineering and medical device researchers.
• Organ-on-a-Chip and Lab-on-a-Chip Platforms Microphysiological system platforms for disease modeling, drug testing, and personalized medicine, including tumor-on-chip, bone marrow-on-chip, and skin-tissue models using human induced pluripotent stem cells. Targeted at pharmaceutical companies and clinical researchers.
• Biosensor Development Custom development of biosensors for detection of specific analytes, including aptamer-based sensors for drug residues, thrombotic disease diagnostics, and environmental pollutant detection using impedance spectroscopy. Targeted at medical diagnostics and environmental monitoring organizations.
• Biomaterial Surface Functionalization Surface modification and functionalization services using tetraetherlipids (TEL), polyelectrolyte multilayers (PEM), plasma treatment, and anti-adhesive coatings for medical implants to improve biocompatibility and prevent infections. Targeted at medical device manufacturers.
• Cellular Analysis and Characterization Services Comprehensive cell analysis services including 3D cell culture, spheroid formation, tumor model development, stem cell research, and high-throughput drug response evaluation with IC50 determination. Targeted at pharmaceutical, biotechnology, and clinical research clients.

Quantifiable outcome

• 30% higher specificity for HIT antibody detection compared to standard ELISA
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature6 records

Partnerships

Two partnerships are on record, tiered core.

• Universitätsklinikum Jena (UKJ) - Institut für Infektionsmedizin und Krankenhaushygiene (IIMK)coreStrategic or Co-development PartnerThe institute collaborates with the University Hospital Jena's Institute for Infectious Medicine and Hospital Hygiene (IIMK) within the GUARDIAN research group focused on nanoparticle-based drug delivery systems for treating infectious endocarditis. The joint project (FGR GUARDIAN) aims to develop tetraether lipid-based nanoparticulate drug delivery systems and establish a biofilm model covering the clinically relevant spectrum of infectious endocarditis pathogens.
• Microfluidic ChipShop GmbHcoreStrategic or Co-development PartnerThe institute collaborates with Microfluidic ChipShop GmbH as the coordinator in the 3D-ToCA (3D-Tumor-On-Chip-Application) joint project alongside Universitätsklinikum Jena as clinical partner. The project focuses on individually designed 3D matrices and biosensors for tumor-on-chip applications, advancing disease modeling research in Thuringia and Germany.

Recent moves6 records

Expansion highlights5 records

Direct peers

• InSphero: InSphero specializes in 3D microtissue (spheroid) models and high-throughput drug screening — directly overlapping with IBA's 3DµHTS droplet-based platform and 3D cell culture / tumor modeling work.
• Microfluidic ChipShop: Microfluidic ChipShop manufactures microfluidic chips and lab-on-a-chip systems — an existing IBA partner in the 3D-ToCA project and a direct peer in microfluidic chip technologies.
• Mimetas: Mimetas provides the OrganoPlate microfluidic 3D cell culture platform for organ-on-chip applications — a directly comparable microfluidic organ-on-chip offering to IBA's modular microfluidic and tumor-on-chip platforms.
• Fluigent: Fluigent supplies microfluidic flow control and droplet generation instruments — directly comparable to IBA's droplet-based microfluidic platform for high-throughput screening.
• TissUse: TissUse develops multi-organ-on-chip platforms for drug testing and disease modeling, closely paralleling IBA's organ-on-chip and disease modeling offerings including bone marrow niche-on-chip.
• Emulate: Emulate develops the Emulate organ-on-chip platform (Liver-Chip, etc.) for drug discovery and toxicity testing — a leading commercial peer to IBA's organ-on-chip and disease modeling work.
• CN Bio: CN Bio offers organ-on-chip and microphysiological systems for preclinical drug discovery — directly comparable to IBA's organ-on-chip and 3D cell culture capabilities.
• Nanion Technologies: Nanion specializes in bioimpedance and TEER measurement instruments for life sciences — directly comparable to IBA's broadband bioimpedance spectroscopy capabilities for biological material characterization.

Broad incumbents

• Sartorius: Sartorius is a global bioprocessing equipment and lab products incumbent with overlapping bioprocess engineering and cell analysis capabilities, though operating at vastly greater scale and breadth than IBA.
• Cytiva: Cytiva (part of Danaher) provides bioprocessing instruments, consumables, and analytical measurement systems used across the biopharma workflow — a broad incumbent in the same bioprocessing/analytical measurement category as IBA.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/watch?v=q3xllJq78xU
• LinkedInlinkedin.com/company/institut-f-r-bioprozess-und-analysenme-technik-e-v-

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Institute for Bioprocessing and Analytical Measurement Techniques e.V.